|Articles|January 21, 2016

Celltrion Adopts Medidata Clinical Cloud

Medidata's ClinicalCloud will provide scalable technology to Celltrion's biosimilars development programs.

Seoul, Korea-based biopharmaceutical company Celltrion announced it has adopted Medidata's ClinicalCloud to provide scalable technology to its biosimilars development programs. The technologies include electronic data capture and management (Medidata Rave®), medical coding (Medidata Coder®) and randomization and trial supply management (Medidata Balance®).

 

Read the full release.

 

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content